In Estonia, the government allocated €5 million ($5.9 million) to support the genotyping of 100,000 people in the Northern European country next year. The Estonian Genome Project began in 2000 and as part of this new phase of the project, they will collect genetic data and report back genetic risks. Their goal is to implement personalized medicine in Estonia “to prevent common diseases such as type II diabetes and cardiovascular disease,” Lili Milani, senior scientist and head of pharmacogenomics at the Estonian Genome Center told GenomeWeb.
The Estonian Genome Center will use Illumina’s Global Screening Array to genotype the new samples. All DNA extraction and genotyping will be done at the Estonian Genome Center’s core facility, Milani told GenomeWeb.